Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) Purchase of Investments (2025)

Updated

Analysis

Drugs Made In America Acquisition (DMAA) Purchase of Investments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 461.00 Mn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - -1.03 Bn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 20.96 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - 312.00 Mn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn 30.94 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn -37.64 Mn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn -
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 231.15 Mn
API Access

Drugs Made In America Acquisition Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=DMAA&period=max&api_key=YOUR_API_KEY